Publications by authors named "Brian Steingo"

Claim this Profile
S
Satralizumab treatment in adults with aquaporin-4 immunoglobulin G-seropositive neuromyelitis optica spectrum disorder in clinical practice.
Hesham Abboud, Brian Steingo, Diana Vargas, Julie Patel, Mary Alissa Willis

Mult Scler J Exp Transl Clin· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Satralizumab treatment in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder after rituximab treatment: A case series.
Hesham Abboud, Brian Steingo, Diana Vargas, Julie Patel, Nancy Nealon

J Neuroimmunol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune response to influenza vaccine in patients with relapsing multiple sclerosis treated with ofatumumab: Results from an open-label, multicenter, phase 4 study.
Brian Steingo, Adnan Subei, Emily Riser, Jeffrey Gitt, James Stankiewicz

Mult Scler Relat Disord· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of alemtuzumab over 6 years in relapsing-remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies.
Bart Van Wijmeersch, Barry A Singer, Aaron Boster, Simon Broadley, Óscar Fernández, Brian Steingo

Mult Scler· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and safety of alemtuzumab in patients with RRMS: 12-year follow-up of CAMMS223.
Brian Steingo, Yaser Al Malik, Ann D Bass, Regina Berkovich, Matthew Carraro

J Neurol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune thrombocytopenia in alemtuzumab-treated MS patients: Incidence, detection, and management.
Adam Cuker, Ann D Bass, Congor Nadj, Mark A Agius, Brian Steingo

Mult Scler· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Alemtuzumab in Patients of African Descent with Relapsing-Remitting Multiple Sclerosis: 8-Year Follow-up of CARE-MS I and II (TOPAZ Study).
Annette F Okai, Lilyana Amezcua, Regina R Berkovich, Angel R Chinea, Keith R Edwards, Brian Steingo

Neurol Ther· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of a switch to fingolimod versus staying on glatiramer acetate or beta interferons on patient- and physician-reported outcomes in relapsing multiple sclerosis: post hoc analyses of the EPOC trial.
Jonathan Calkwood, Bruce Cree, Heidi Crayton, Daniel Kantor, Brian Steingo

BMC Neurol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CLIPPERS complicating multiple sclerosis causing concerns of CNS lymphoma.
Melissa R Ortega, Nida Usmani, Carlos Parra-Herran, David J Adams, Brian Steingo

Neurology· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis